The cross-face nerve graft (CFNG) is a microsurgical procedure that creates a new neural connection between the functioning facial nerve on the healthy side and the paralyzed side of the face. A segment of sural nerve — harvested from the lower leg — serves as a biological cable, carrying the electrical signals that drive spontaneous facial expression across the midline of the face.
What makes this procedure unique in the world of facial reanimation is its ability to restore emotion-driven movement. Because the nerve graft taps into the patient's own facial nerve on the working side, the signals it carries are the same ones that produce natural smiling, laughing, and emotional expression. This stands in contrast to nerve transfers from other motor nerves, which require conscious retraining to activate. The CFNG is typically the first stage of a two-stage reconstruction, with a gracilis free muscle transfer following 12 to 18 months later.
The cross-face nerve graft is performed under general anesthesia and takes approximately 3.5 hours. It is an outpatient procedure — patients go home the same day.
The sural nerve is a sensory nerve located along the back of the lower leg. Through a small incision behind the ankle, Dr. Panossian harvests a segment of this nerve to serve as the graft conduit. The sural nerve is an ideal donor because it is long enough to span the distance across the face, has an appropriate caliber for microsurgical coaptation, and its removal causes no meaningful functional deficit — it supplies sensation to a small patch on the outer edge of the foot, which most patients never notice.
On the healthy side of the face, Dr. Panossian identifies a functioning branch of the facial nerve — typically one of the buccal branches responsible for smiling. Using intraoperative nerve stimulation, he confirms which branch produces the desired movement while ensuring that sacrificing a small portion of its signal will not create noticeable weakness on the healthy side. The redundancy of the facial nerve's branching pattern allows this "borrowing" without functional consequence.
The sural nerve graft is microsurgically sutured to the identified facial nerve branch on the healthy side. The graft is then tunneled across the upper lip — beneath the skin and above the muscle — to the paralyzed side of the face. The distal end is carefully positioned and "banked" (left in a protected location) where it will later be connected to the transplanted gracilis muscle during the second stage of reconstruction.
Over the following 12 to 18 months, nerve fibers from the healthy facial nerve slowly grow through the sural nerve graft at a rate of approximately one millimeter per day. This regeneration process is monitored clinically and with Tinel's sign testing — a tapping technique that tracks the advancing front of nerve growth across the face. When the nerve fibers have reached the banked end on the paralyzed side, the patient is ready for the second stage: gracilis free muscle transfer.
The cross-face nerve graft is the foundation of a two-stage approach to facial reanimation that prioritizes the most natural possible outcome — a spontaneous, emotion-driven smile.
The CFNG is an outpatient procedure with a relatively straightforward recovery compared to the second-stage muscle transfer.
A small surgical drain is placed at the time of surgery and removed at the first postoperative visit, typically within two days. Mild swelling and bruising along the cheek and upper lip are normal. Pain is generally well-controlled with prescribed medications.
A soft diet is recommended for the first three weeks to minimize stress on the surgical site along the upper lip. Most patients take 7 to 10 days off work before returning to desk-level activities. Strenuous exercise, heavy lifting, and contact sports should be avoided during this period.
Light activity resumes at four weeks. The leg donor site heals quickly — the small incision behind the ankle causes minimal discomfort, and the sensory deficit from sural nerve harvest is typically unnoticeable in daily life. From this point, the primary task is patience: waiting for the nerve graft to regenerate across the face over the following 12 to 18 months.
Dr. Panossian tracks nerve regeneration through regular follow-up visits using Tinel's sign — a clinical test that tracks the advancing front of nerve growth by tapping along the graft's course. When the nerve fibers have reached the paralyzed side, the patient is scheduled for the second-stage gracilis transfer. Physical therapy begins at this point to prepare for the muscle transplant.
One of the most common questions patients ask is about the nerve harvested from the leg. The sural nerve is a purely sensory nerve that runs along the back of the calf and behind the ankle. It supplies sensation to a small area on the outer edge of the foot — a region with redundant sensory coverage from adjacent nerves.
Harvesting the sural nerve does not affect walking, balance, or leg strength in any way. Some patients notice a small patch of numbness on the outer foot that gradually diminishes over time. The harvest incision is small — typically 3 to 4 centimeters behind the ankle — and heals with a thin, inconspicuous scar.
The sural nerve has been the gold-standard donor nerve in reconstructive microsurgery for decades, prized for its length, consistent anatomy, and minimal donor-site morbidity. It is the same nerve used in peripheral nerve reconstruction throughout the body.
The cross-face nerve graft is a technically demanding procedure that requires not only microsurgical precision but also deep experience in facial nerve anatomy and the strategic planning of multi-stage reconstruction. Selecting the right donor branch, harvesting the appropriate graft length, achieving precise coaptation, and routing the graft through the correct tissue planes all directly impact the final outcome — a natural, spontaneous smile months or years later.
Dr. Andre Panossian trained in facial reanimation under Dr. Ron Zuker at the Hospital for Sick Children in Toronto — one of the world's foremost centers for this surgery — and completed craniofacial fellowship training at Harvard Medical School. His experience spans the full spectrum of facial paralysis, from congenital cases in children to complex adult reconstructions following tumor surgery, trauma, and Bell's palsy.
Every cross-face nerve graft Dr. Panossian performs is part of a comprehensive treatment plan designed around the individual patient's anatomy, goals, and timeline. From the initial consultation through the second-stage procedure and long-term follow-up, he guides each patient through every phase of the reanimation journey.
The nerve graft needs time — typically 12 to 18 months — for nerve fibers from the healthy facial nerve to grow through the sural nerve conduit and reach the paralyzed side. Only after the graft has matured and is carrying a viable neural signal can the gracilis muscle be transplanted and connected. Attempting both stages simultaneously would mean connecting the muscle to a graft that has no signal yet, resulting in muscle atrophy before innervation arrives. The two-stage approach ensures the neural pathway is established before the muscle is placed.
No. The sural nerve is purely sensory — it has nothing to do with motor function, walking, or balance. Its only role is supplying sensation to a small patch on the outer edge of the foot. After harvest, some patients notice mild numbness in this area that typically fades over time. The vast majority of patients report no noticeable change in their daily activities.
The initial recovery is relatively quick. Most patients return to work within 7 to 10 days. A soft diet is maintained for three weeks, and light activity resumes at four weeks. The drain placed during surgery is removed within two days. The longer timeline — 12 to 18 months — is the nerve regeneration period before the second stage can be performed.
The primary advantage is spontaneity. Because the CFNG carries signals from the patient's own facial nerve, the resulting smile occurs naturally with emotion — laughing, smiling at a loved one, reacting to a surprise. A masseteric nerve transfer, by contrast, produces a strong smile driven by the bite-clenching nerve, which initially requires conscious effort to activate (though many patients develop some spontaneity over time). Dr. Panossian discusses both options with every patient to determine which approach best aligns with their goals and timeline.
If you're living with facial paralysis and seeking a solution that restores natural, spontaneous expression, the cross-face nerve graft may be the right path. Schedule a consultation with Dr. Panossian to discuss your options.
Request a Consultation